The cost of drug development

New England Journal of Medicine

Volumn 372, Issue 20, 2015, Pages 1972-

  Di Masi, Joseph A ^a   Grabowski, Henry G ^b   Hansen, Ronald W ^c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

DRUG COST; DRUG INDUSTRY; DRUG RESEARCH; FINANCIAL MANAGEMENT; FUNDING; GOVERNMENT; HUMAN; LETTER; METHODOLOGY; NON PROFIT ORGANIZATION; PRIORITY JOURNAL; TREATMENT FAILURE; DRUG DEVELOPMENT; ECONOMICS;

DRUG COSTS; DRUG DISCOVERY; DRUG INDUSTRY; FINANCING, GOVERNMENT;

EID: 84930008613     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1504317     Document Type: Letter

References (5)

1. Avorn J. The $2.6 billion pill - methodologic and policy considerations. N Engl J Med 2015;372:1877-9.
2. DiMasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&D costs. Boston: Tufts Center for the Study of Drug Development, November 18, 2014 (http://csdd.tufts.edu/news/complete-story/cost-study-press-event-webcast).
3. Chakravarthy R, Cotter K, DiMasi JA, Milne C-P, Wendel N. Public and private sector contributions to the research and development of the most transformational drugs of the last 25 years. Boston: Tufts Center for the Study of Drug Development, January 2015 (http://csdd.tufts.edu/files/uploads/PubPrivPaper2015.pdf).
4. How the Tufts Center for the Study of Drug Development pegged the cost of a new drug at $2.6 billion. Boston: Tufts Center for the Study of Drug Development, November 18, 2014 (http://csdd.tufts.edu/files/uploads/cost-study-backgrounder.pdf).
5. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ 2003;22:151-85.